ECCA, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 596
EU - Europa 171
AS - Asia 93
SA - Sud America 16
OC - Oceania 4
AF - Africa 3
Totale 883
Nazione #
US - Stati Uniti d'America 589
IT - Italia 63
SG - Singapore 33
CN - Cina 31
DE - Germania 22
RU - Federazione Russa 19
FR - Francia 15
BR - Brasile 14
UA - Ucraina 14
IE - Irlanda 12
TR - Turchia 10
CA - Canada 7
FI - Finlandia 6
GB - Regno Unito 6
SE - Svezia 6
NZ - Nuova Zelanda 4
VN - Vietnam 4
CY - Cipro 2
IQ - Iraq 2
JP - Giappone 2
KR - Corea 2
TW - Taiwan 2
AT - Austria 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
MA - Marocco 1
MD - Moldavia 1
NL - Olanda 1
NO - Norvegia 1
PK - Pakistan 1
SA - Arabia Saudita 1
TG - Togo 1
Totale 883
Città #
Fairfield 103
Houston 50
Seattle 45
Cambridge 43
Woodbridge 43
Ashburn 42
Wilmington 41
Ann Arbor 26
Chandler 24
Dearborn 24
Singapore 19
Udine 13
Boardman 12
Dublin 12
Beijing 10
Izmir 9
Princeton 9
Jacksonville 8
Munich 6
Turku 6
Des Moines 5
Los Angeles 5
Auckland 4
Cagliari 4
Cormons 4
Dong Ket 4
Düsseldorf 4
London 4
Naples 4
Ogden 4
Redmond 4
Rome 4
Shenzhen 4
Toronto 4
Chengdu 3
Nanjing 3
Ottawa 3
Palermo 3
San Diego 3
Azzano Decimo 2
Bitonto 2
Council Bluffs 2
Lauterbourg 2
Milan 2
Nicosia 2
Nuremberg 2
Phoenix 2
Redwood City 2
Sulaymaniyah 2
Wuhan 2
Abidjan 1
Andover 1
Apucarana 1
Bahawalpur 1
Baku 1
Boston 1
Brooklyn 1
Brussels 1
Buffalo 1
Cabo Frio 1
Campo Maior 1
Catanduva 1
Ceccano 1
Chisinau 1
Deiva Marina 1
Esmeraldas 1
Frankfurt am Main 1
Fuzhou 1
Genova 1
Guangzhou 1
Hangzhou 1
Iguatu 1
Jardim 1
Jinan 1
La Paz 1
Laives 1
Las Vegas 1
Lavras 1
Lomé 1
Lorena 1
Manama 1
Marco 1
Miami 1
Milwaukee 1
Minneapolis 1
Monte Alegre de Minas 1
Novokuznetsk 1
Padova 1
Piemonte 1
Polcenigo 1
Portsmouth 1
Rabat 1
Rio de Janeiro 1
Riyadh 1
San Francisco 1
Santa Clara 1
Santiago 1
Seoul 1
Shenyang 1
Stockholm 1
Totale 690
Nome #
PHARMACOGENETICS OF FLUOROPYRIMIDINES: FROM THE IMPLEMENTATION OF GUIDELINES TO IDENTIFICATION OF NOVEL GERMLINE VARIANTS RELATED TO TOXICITY 147
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) 126
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 122
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity 105
Immunogenetics of prostate cancer: A still unexplored field of study 86
The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines 83
Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation 77
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 76
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 57
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk 45
Totale 924
Categoria #
all - tutte 3.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 0 0 9
2020/2021157 2 33 1 20 10 13 32 13 11 7 7 8
2021/202279 7 6 3 2 4 4 3 1 3 19 17 10
2022/202388 9 0 1 20 6 31 0 2 8 0 3 8
2023/202460 6 0 2 0 20 5 5 4 7 1 0 10
2024/2025194 10 15 3 13 19 11 18 29 33 11 29 3
Totale 924